List of Next-Gen Sequencing Companies in Israel - 3

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. Leveraging NGS-based and PCR-based technology to identify methylation changes, the Company's pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. The Company's non-invasive EpiCheck® delivers highly accurate and sensitive results, all while providing a seamless testing option for physicians, patients, and the healthcare system. The Company is building an EpiCheck® franchise, beginning with the Bladder EpiCheck® kit, CE-marked and available in Europe for primary and recurrent bladder cancer and upper tract urinary cancer, and FDA 510(k) cleared for bladder cancer recurrence in the United States. The Company is advancing its Lung EpiCheck® test towards commercialization for high-risk individuals while evaluating additional tests for other high-risk diseases.

Olive Diagnostics is a health technology startup founded in 2019 and based in Jerusalem, Israel. The company focuses on developing innovative, non-invasive health monitoring technologies aimed at empowering individuals with continuous insights into their health data. This approach supports healthier lifestyles and improved healthcare outcomes. The company specializes in digital diagnostics, particularly with its non-invasive urinalysis sensor, the Olive KG. This device mounts to any toilet and utilizes optics, IoT technology, AI, and data analysis to provide real-time health alerts and disease detection. It is designed for early disease detection and chronic disease management by continuously collecting and analyzing health data, offering users historical insights and proactive health tips. Olive Diagnostics has a multidisciplinary team with expertise in various fields, including biochemistry and data analytics. The company is in the final stages of research and development and plans to launch its product by the end of 2024, positioning itself for growth in the digital diagnostics market.

RCK is an Israeli cannabis company, breeding repeatable & stable cannabis hybrid-seeds, for both medical & recreational markets.